CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanghai Fudan Forward S&T Co Ltd Company Snapshot
Shanghai Fudan Forward S&T Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Fudan Forward S&T Co Ltd with three other companies in this sector in China: Zhejiang Starry Pharmaceutical Co Ltd (2016 sales of 672.75 million Chinese Renmimbi [US$101.70 million] of which 99% was Pharmaceuticals Industry), Coland Holdings Limited (675.24 million Chinese Renmimbi [US$102.08 million] of which 100% was Medical Services), and Ginwa Enterprise Group Inc. (666.08 million Chinese Renmimbi [US$100.69 million] of which 73% was Pharmaceutical Industry).

Sales Analysis. During the year ended December of 2016, sales at Shanghai Fudan Forward S&T Co Ltd were 670.57 million Chinese Renmimbi (US$101.37 million). This is a decrease of 6.3% versus 2015, when the company's sales were 715.69 million Chinese Renmimbi. The sales level in 2016 was fairly close to the level five years ago: in 2011, Shanghai Fudan Forward S&T Co Ltd had sales of 725.11 million Chinese Renmimbi. Contributing to the drop in overall sales was the 11.3% decline in Industrial, from 422.85 million Chinese Renmimbi to 375.09 million Chinese Renmimbi. . However, these declines were partially offset by the increase in sales of Software Development (up 12.6% to 259.75 million Chinese Renmimbi) and Other Operations (up 193.6% to 36.40 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Fudan Forward S&T Co Ltd
  Stock Performance Chart for Shanghai Fudan Forward S&T Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 6.73
(Figures in Chinese Renmimbi)
1 Week -1.9%   13 Weeks -9.2%  
4 Weeks -14.8%   52 Weeks -23.4%  
 
Shanghai Fudan Forward S&T Co Ltd Key Data:
  Ticker: 600624 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 670,566,489
(Year Ending Jan 2017).
Employees: 1,620
  Currency: Chinese Renmimbi Market Cap: 4,608,111,827
  Fiscal Yr Ends: December Shares Outstanding: 684,712,010
  Share Type: A Gu Closely Held Shares: 253,766,419
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.